See the DrugPatentWatch profile for Quillivant
The manufacturer of Quillivant, an extended-release methylphenidate oral suspension, is Viatris (formerly Mylan) [1]. For individuals seeking financial assistance with their medication costs in 2021, Viatris offered a savings card program for eligible patients [2].
How do Viatris savings cards work for Quillivant?
Viatris's savings card program for Quillivant was designed to help eligible commercially insured patients reduce their out-of-pocket prescription costs [2]. Patients could typically obtain these cards through Viatris's website or through their healthcare provider [2]. The card would then be presented at the pharmacy during checkout to apply the discount [2].
What was the typical savings amount for Quillivant in 2021?
In 2021, the Viatris savings card for Quillivant typically offered savings of up to a certain dollar amount or a percentage off the co-pay, subject to program terms and conditions [2]. Specific savings amounts could vary based on the patient's insurance plan and the prevailing retail price of the medication [2].
Who qualifies for Quillivant manufacturer coupons?
Eligibility for Viatris's Quillivant savings card in 2021 was generally limited to patients with commercial prescription insurance coverage [2]. Patients covered by government healthcare programs, such as Medicare, Medicaid, or TRICARE, were typically not eligible for these savings cards [2]. There were also other conditions, such as maximum savings limits and program expiry dates, that applied [2].
Are there Quillivant discount programs available now?
Viatris continues to offer savings programs for its medications. To find the most current information on discount programs for Quillivant, it is advisable to check the official Viatris website or consult with a healthcare provider or pharmacist [2]. These programs can change periodically.
What other financial assistance options exist for Quillivant?
Beyond manufacturer coupons, patients may explore other avenues for financial assistance. These can include patient assistance programs (PAPs) offered by the manufacturer or other organizations, which may provide medication at a reduced cost or for free to eligible uninsured or underinsured patients [3]. Additionally, prescription discount cards from third-party providers or pharmacy discount programs can sometimes offer savings [3]. Some non-profit organizations also offer financial aid for prescription medications [3].
When does Quillivant's patent expire?
Information regarding the specific patent expiry dates for Quillivant can be tracked through resources like DrugPatentWatch.com [4]. Patent information is crucial for understanding when generic versions of a drug may become available.
Can generic versions of Quillivant be expected?
The availability of generic versions of Quillivant depends on the expiry of relevant patents and any other market exclusivities. Once these protections expire, other pharmaceutical companies may be able to manufacture and market generic equivalents of the drug, potentially leading to lower prices [4].
What are the reported side effects of Quillivant?
Common side effects associated with Quillivant, like other methylphenidate products, can include decreased appetite, weight loss, insomnia, nausea, vomiting, and anxiety [5]. Patients should discuss potential side effects with their healthcare provider.
Sources:
1. Viatris Website (general information on the company)
2. Viatris Savings Card Information (archived or general program details)
3. Patient Assistance Programs (general concept and potential resources)
4. DrugPatentWatch.com
5. FDA Label Information (general reference for methylphenidate products)